西点药业

301130.SZ

Wind Industry: 医疗保健 > 医药生物 > 制药 > 西药

公司是一家专注于化学药品原料药及制剂研发、生产、销售的科技型医药企业，是吉林省首批通过“高新技术企业”认定的医药企业之一。公司总部位于吉林省，拥有两大生产基地，分别坐落于吉林省磐石经济开发区与吉林经济循环化工园区。生产基地均严格遵循GMP标准，建设有口服固体制剂、口服溶液剂、原料药以及中药现代化提取车间在内的多元化生产线，构建了完整的产业布局。公司经过三十余年差异化发展道路，形成了以抗贫血用药、治疗循环障碍用药、治疗精神障碍用药、原料药为核心的产品体系，“原料药+制剂”一体化优势突出，致力于成为拥有突出核心产品优势、较强研发实力，较高品牌知名度的医药制造企业。公司贯彻创新驱动发展战略，持续强化创新能力，拥有支撑企业发展的关键技术和自主知识产权，通过技术成果转化和技术进步带动经济效益提升。公司多年来连续盈利，细分市场占有率在同类产品中处于前列，先后被评为“国家级高新技术企业”“国家火炬计划重点高新技术企业”。

ESG Score Industry Ranking:
2 / 282 (制药)

ESG Rating Distribution(制药)

0.35%

AAA

2.84%

17.73%

20.21%

BBB

30.14%

24.11%

0.35%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.39Updated on 2026-10-29

08.3910

Management & Practices Score：5.39Updated on 2026-09-18

05.397

Controversies Score：3.00Updated on 2026-10-29

03.003

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	7.28	3.56	22.85%
Social	7.78	3.72	49.76%
Governance	7.92	5.34	27.39%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(282 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	600535.SH	天士力	AAA	8.94	3.00	5.94	9.07	8.63	7.75
2	301130.SZ	西点药业	AA	8.39	3.00	5.39	7.28	7.78	7.92
3	3320.HK	华润医药	AA	8.31	3.00	5.31	7.23	7.73	7.62
4	600380.SH	健康元	AA	8.22	3.00	5.22	5.64	8.16	7.66
5	603896.SH	寿仙谷	AA	8.18	3.00	5.18	6.54	7.51	7.92
6	600329.SH	达仁堂	AA	8.15	3.00	5.15	6.24	7.44	8.16
7	601607.SH	上海医药	AA	8.07	3.00	5.07	7.19	7.17	7.40
8	000999.SZ	华润三九	AA	8.03	3.00	5.03	7.66	7.39	6.42
9	301281.SZ	科源制药	A	7.99	2.99	4.99	5.58	7.51	7.72
10	000513.SZ	丽珠集团	AA	7.94	2.99	4.94	5.51	7.94	6.76